GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the C-terminal gaf domain of human phosphodiesterase 10A

Analyse Crystal structure of the C-terminal gaf domain of human phosphodiesterase 10A in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZMF
Type
protein
Length
349 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17
UniProt
Q9Y233
Ligands
CMP
Pockets
8 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)protein17742% helix, 27% strandQ9Y233
BCamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)protein17240% helix, 30% strandQ9Y233

Ligands and binding sites

  • CMP · Adenosine-3',5'-cyclic-monophosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11030.780.9723CMP
21030.780.9722CMP
33740.620.7736empty
41180.380.7421empty
5610.360.7813empty

Interfaces

1 interface between chains.

  • A–B · 1559 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 modified (engineered).

Compared structures

  • 2ZMF · Crystal structure of the C-terminal GAF domain of human phosphodiesterase 10A · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.